Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SALIX PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 120.15 M 111.27 M 76.46 M 68.18 M 52.11 M
    Net Receivables 40.46 M 52.21 M 61.73 M 38.85 M 10.46 M
    Total Inventories 17.31 M 17.68 M 25.12 M 23.16 M 26.66 M
    Progress Payments & Others 11,000.00 -24,000.00 23,000.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 8.30 M 14.22 M 6.81 M 6.58 M 1.87 M
    Current Assets Total 186.22 M 195.38 M 170.12 M 136.78 M 91.09 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 15.00 M 0.00 0.00 0.00 0.00
    Property, Plant & Equipment Net 4.85 M 5.88 M 3.87 M 3.78 M 2.28 M
    Property, Plant & Equipment Gross 13.89 M 11.98 M 8.10 M 6.77 M 4.28 M
    Accumulated Depreciation 9.04 M 6.11 M 4.24 M 2.99 M 1.99 M
    Other Assets 195.08 M 195.85 M 149.13 M 141.92 M 14.49 M
    Deferred Charges
    Tangible Other Assets 3.00 M 3.75 M 0.00 0.00 0.00
    Intangible Other Assets 192.08 M 192.10 M 149.13 M 141.92 M 14.49 M
    Total Assets 401.15 M 397.10 M 323.12 M 282.47 M 107.86 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 849,000.00 1.01 M 0.00 0.00 0.00
    Accrued Payroll 5.49 M 10.26 M
    Income Taxes Payable 0.00 0.00 0.00 114,000.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 61.48 M 73.59 M 33.58 M 23.17 M 16.76 M
    Current Liabilities Total 72.42 M 86.48 M 44.98 M 42.26 M 21.18 M
    Long Term Debt 77.90 M 15.61 M 0.00 0.00 0.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 0.00 0.00 0.00 0.00 0.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 0.00 2.44 M 592,000.00 360,000.00 0.00
    Total Liabilities 150.32 M 104.53 M 45.57 M 42.62 M 21.18 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 250.82 M 292.57 M 277.55 M 239.85 M 86.69 M
    Common Stock 48,000.00 47,000.00 47,000.00 46,000.00 37,000.00
    Capital Surplus 402.55 M 397.26 M 390.47 M 384.96 M 171.21 M
    Revaluation Reserves
    Other Appropriated Reserves 0.00 0.00 0.00 -679,000.00 -676,000.00
    Unappropriated (Free) Reserves
    Retained Earnings -151.78 M -104.74 M -112.96 M -144.47 M -83.89 M
    Equity in Untaxed Reserves
    ESOP Guarantees
    Unrealized Foreign Exchange Gain (Loss) 0.00
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 0.00 0.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 401.15 M 397.10 M 323.12 M 282.47 M 107.86 M
    Common Shares Outstanding 48.08 M 47.71 M 47.03 M 46.31 M 36.51 M